Tasha A. Morrison, Ph.D., M.P.H., received her bachelor’s degree in biology from Temple University in 2005. Her interest in basic science research led her to start a summer internship in the laboratory of Dr. Elizabeth Henske at the Fox Chase Cancer Center. It transitioned into a post-baccalaureate position funded by the NIH/NIDDK to study molecular mechanisms of renal malignancy in tuberous sclerosis. 
 
In 2008, Dr. Morrison moved with Dr. Henske to Brigham and Women’s Hospital as a research assistant and changed her focus to the role of estrogen in the malignancy of lymphangioleiomyomatosis. While at Brigham, she received a master’s degree in public health at Boston University. 
 
In 2012, Dr. Morrison started a molecular and translational medicine doctoral program at Boston University School of Medicine. She characterized a novel long non-coding RNA and determined its role in regulating hemoglobin expression in red blood cells. This research was partially funded by an F31 predoctoral fellowship grant awarded by the NIH/NHLBI. 
 
After successfully defending her doctoral thesis in 2017, Dr. Morrison joined the laboratory of Dr. John O’Shea as a postdoctoral fellow at the NIAMS. Her research focuses on the role of genes found within super-enhancers specific to natural killer (NK) cells. In 2020, Dr. Morrison was selected to join the Independent Research Scholar Program. She holds a junior faculty position at the NIAMS and leads the Lymphocyte Signaling Unit.